HTA351 Use of the ESMO-Magnitude of Clinical Benefit Scale to Guide HTA Recommendations on Coverage and Reimbursement for Cancer Medicines in Ireland: A Retrospective Analysis
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.2134
https://www.valueinhealthjournal.com/article/S1098-3015(25)04691-1/fulltext
Title :
HTA351 Use of the ESMO-Magnitude of Clinical Benefit Scale to Guide HTA Recommendations on Coverage and Reimbursement for Cancer Medicines in Ireland: A Retrospective Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)04691-1&doi=10.1016/j.jval.2025.09.2134
First page :
Section Title :
Open access? :
No
Section Order :
11685